Movement Alert｜WuXi AppTec Rises 3.14% in Regular Trading, CXO Sector Strengthens as Morgan Stanley Raises Target Price

Market Focus07-06

On July 6, WuXi AppTec rose 3.14% in regular trading, trading at 160.5 HKD/share, with turnover of 3.11 billion HKD.

On the news front, the life sciences tools and services sector rallied collectively, with WuXi XDC up 6.4%, XtalPi up 6.71%, and GenScript Biotech up 5.95%, while Morgan Stanley raised its H-share target price from 155 HKD to 168 HKD and reaffirmed the stock as its top pick.

Morgan Stanley lifted its adjusted earnings forecasts for the company from fiscal year 2026 to 2028 by 4% to 6%, implying a compound annual growth rate of 16%. The bank expects the company's strong performance to continue through 2027, with potential upward revisions to full-year guidance. Additionally, the company has completed both its 1 billion RMB A-share buyback and 2.5 billion HKD H-share buyback programs, with repurchased shares designated for employee stock ownership plans, signaling management confidence in intrinsic value.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104832577?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-06 10:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104832577","market":"hk","top_or_hot":-1,"title":"Movement Alert｜WuXi AppTec Rises 3.14% in Regular Trading, CXO Sector Strengthens as Morgan Stanley Raises Target Price","media":"Market Focus","content":"<p><p>On July 6, WuXi AppTec rose 3.14% in regular trading, trading at 160.5 HKD/share, with turnover of 3.11 billion HKD.</p><p>On the news front, the life sciences tools and services sector rallied collectively, with WuXi XDC up 6.4%, XtalPi up 6.71%, and GenScript Biotech up 5.95%, while Morgan Stanley raised its H-share target price from 155 HKD to 168 HKD and reaffirmed the stock as its top pick.</p><p>Morgan Stanley lifted its adjusted earnings forecasts for the company from fiscal year 2026 to 2028 by 4% to 6%, implying a compound annual growth rate of 16%. The bank expects the company's strong performance to continue through 2027, with potential upward revisions to full-year guidance. Additionally, the company has completed both its 1 billion RMB A-share buyback and 2.5 billion HKD H-share buyback programs, with repurchased shares designated for employee stock ownership plans, signaling management confidence in intrinsic value.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi AppTec Rises 3.14% in Regular Trading, CXO Sector Strengthens as Morgan Stanley Raises Target Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi AppTec Rises 3.14% in Regular Trading, CXO Sector Strengthens as Morgan Stanley Raises Target Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-06 10:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 6, WuXi AppTec rose 3.14% in regular trading, trading at 160.5 HKD/share, with turnover of 3.11 billion HKD.</p><p>On the news front, the life sciences tools and services sector rallied collectively, with WuXi XDC up 6.4%, XtalPi up 6.71%, and GenScript Biotech up 5.95%, while Morgan Stanley raised its H-share target price from 155 HKD to 168 HKD and reaffirmed the stock as its top pick.</p><p>Morgan Stanley lifted its adjusted earnings forecasts for the company from fiscal year 2026 to 2028 by 4% to 6%, implying a compound annual growth rate of 16%. The bank expects the company's strong performance to continue through 2027, with potential upward revisions to full-year guidance. Additionally, the company has completed both its 1 billion RMB A-share buyback and 2.5 billion HKD H-share buyback programs, with repurchased shares designated for employee stock ownership plans, signaling management confidence in intrinsic value.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02359","symbol_name":"药明康德","start_time":0,"source_url":"","article_id":"1104832577","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104832577","pubTimestamp":1783304543,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 6, WuXi AppTec rose 3.14% in regular trading, trading at 160.5 HKD/share, with turnover of 3.11 billion HKD.On the news front, the life sciences tools and services sector rallied...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02359":"药明康德"},"translate_title":"动向提示|药明康德常规交易涨3.14%大摩上调目标价CXO板块走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":1},"content_text":"On July 6, WuXi AppTec rose 3.14% in regular trading, trading at 160.5 HKD/share, with turnover of 3.11 billion HKD.On the news front, the life sciences tools and services sector rallied collectively, with WuXi XDC up 6.4%, XtalPi up 6.71%, and GenScript Biotech up 5.95%, while Morgan Stanley raised its H-share target price from 155 HKD to 168 HKD and reaffirmed the stock as its top pick.Morgan Stanley lifted its adjusted earnings forecasts for the company from fiscal year 2026 to 2028 by 4% to 6%, implying a compound annual growth rate of 16%. The bank expects the company's strong performance to continue through 2027, with potential upward revisions to full-year guidance. Additionally, the company has completed both its 1 billion RMB A-share buyback and 2.5 billion HKD H-share buyback programs, with repurchased shares designated for employee stock ownership plans, signaling management confidence in intrinsic value.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104832577","isCrawlerRequest":true}